 | • レポートコード：GIR-105X14979 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、水痘生ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。水痘生ワクチンの種類別市場規模（一価ワクチン、多価ワクチン）、用途別市場規模（水痘予防接種、帯状疱疹予防接種、はしか予防接種、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・水痘生ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma Inc.、CSL Limited、Emergent BioSolutions, Inc.、GlaxoSmithKline plc、Johnson & Johnson、MedImmune, LLC、Merck & Co., Inc.、Pfizer, Inc.、Sanofi Pasteur、Serum Institute of India Pvt. Ltd.、Bavarian Nordic、Mitsubishi Tanabe Pharma Corporation、Daiichi Sankyo、Biological E、Panacea Biotec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：一価ワクチン、多価ワクチン ・用途別分析2016年-2026年：水痘予防接種、帯状疱疹予防接種、はしか予防接種、その他 ・水痘生ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・水痘生ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・水痘生ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・水痘生ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・水痘生ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Varicella Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Varicella Live Vaccine size is estimated to be xx million in 2020 from USD 2429.3 million in 2019, with a change of XX% between 2019 and 2020. The global Varicella Live Vaccine market size is expected to grow at a CAGR of 3.1% for the next five years.
Market segmentation
Varicella Live Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monovalent Vaccines
Multivalent Vaccines
Market segment by Application can be divided into
Chicken Pox Immunization
Herpes Zoster Immunization
Measles Immunization
Others
The key market players for global Varicella Live Vaccine market are listed below:
Astellas Pharma Inc.
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
MedImmune, LLC
Merck & Co., Inc.
Pfizer, Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Bavarian Nordic
Mitsubishi Tanabe Pharma Corporation
Daiichi Sankyo
Biological E
Panacea Biotec
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Varicella Live Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Varicella Live Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monovalent Vaccines
1.2.3 Multivalent Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Varicella Live Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chicken Pox Immunization
1.3.3 Herpes Zoster Immunization
1.3.4 Measles Immunization
1.3.5 Others
1.4 Global Varicella Live Vaccine Market Size & Forecast
1.4.1 Global Varicella Live Vaccine Sales in Value (2016-2026))
1.4.2 Global Varicella Live Vaccine Sales in Volume (2016-2026)
1.4.3 Global Varicella Live Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Varicella Live Vaccine Production Capacity Analysis
1.5.1 Global Varicella Live Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Varicella Live Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Varicella Live Vaccine Market Drivers
1.6.2 Varicella Live Vaccine Market Restraints
1.6.3 Varicella Live Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Varicella Live Vaccine Product and Services
2.1.4 Astellas Pharma Inc. Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 CSL Limited
2.2.1 CSL Limited Details
2.2.2 CSL Limited Major Business
2.2.3 CSL Limited Varicella Live Vaccine Product and Services
2.2.4 CSL Limited Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Emergent BioSolutions, Inc.
2.3.1 Emergent BioSolutions, Inc. Details
2.3.2 Emergent BioSolutions, Inc. Major Business
2.3.3 Emergent BioSolutions, Inc. Varicella Live Vaccine Product and Services
2.3.4 Emergent BioSolutions, Inc. Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 GlaxoSmithKline plc
2.4.1 GlaxoSmithKline plc Details
2.4.2 GlaxoSmithKline plc Major Business
2.4.3 GlaxoSmithKline plc Varicella Live Vaccine Product and Services
2.4.4 GlaxoSmithKline plc Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Varicella Live Vaccine Product and Services
2.5.4 Johnson & Johnson Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 MedImmune, LLC
2.6.1 MedImmune, LLC Details
2.6.2 MedImmune, LLC Major Business
2.6.3 MedImmune, LLC Varicella Live Vaccine Product and Services
2.6.4 MedImmune, LLC Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck & Co., Inc.
2.7.1 Merck & Co., Inc. Details
2.7.2 Merck & Co., Inc. Major Business
2.7.3 Merck & Co., Inc. Varicella Live Vaccine Product and Services
2.7.4 Merck & Co., Inc. Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Pfizer, Inc.
2.8.1 Pfizer, Inc. Details
2.8.2 Pfizer, Inc. Major Business
2.8.3 Pfizer, Inc. Varicella Live Vaccine Product and Services
2.8.4 Pfizer, Inc. Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanofi Pasteur
2.9.1 Sanofi Pasteur Details
2.9.2 Sanofi Pasteur Major Business
2.9.3 Sanofi Pasteur Varicella Live Vaccine Product and Services
2.9.4 Sanofi Pasteur Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Serum Institute of India Pvt. Ltd.
2.10.1 Serum Institute of India Pvt. Ltd. Details
2.10.2 Serum Institute of India Pvt. Ltd. Major Business
2.10.3 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Product and Services
2.10.4 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Bavarian Nordic
2.11.1 Bavarian Nordic Details
2.11.2 Bavarian Nordic Major Business
2.11.3 Bavarian Nordic Varicella Live Vaccine Product and Services
2.11.4 Bavarian Nordic Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Mitsubishi Tanabe Pharma Corporation
2.12.1 Mitsubishi Tanabe Pharma Corporation Details
2.12.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.12.3 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Product and Services
2.12.4 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Daiichi Sankyo
2.13.1 Daiichi Sankyo Details
2.13.2 Daiichi Sankyo Major Business
2.13.3 Daiichi Sankyo Varicella Live Vaccine Product and Services
2.13.4 Daiichi Sankyo Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Biological E
2.14.1 Biological E Details
2.14.2 Biological E Major Business
2.14.3 Biological E Varicella Live Vaccine Product and Services
2.14.4 Biological E Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Panacea Biotec
2.15.1 Panacea Biotec Details
2.15.2 Panacea Biotec Major Business
2.15.3 Panacea Biotec Varicella Live Vaccine Product and Services
2.15.4 Panacea Biotec Varicella Live Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Varicella Live Vaccine Sales by Manufacturer
3.1 Global Varicella Live Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Varicella Live Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Varicella Live Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Varicella Live Vaccine Manufacturer Market Share
3.4.2 Top 6 Varicella Live Vaccine Manufacturer Market Share
3.5 Global Varicella Live Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Varicella Live Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Varicella Live Vaccine Market Size by Region
4.1.1 Global Varicella Live Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Varicella Live Vaccine Revenue by Region (2016-2026)
4.2 North America Varicella Live Vaccine Revenue (2016-2026)
4.3 Europe Varicella Live Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Varicella Live Vaccine Revenue (2016-2026)
4.5 South America Varicella Live Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Varicella Live Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Varicella Live Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Varicella Live Vaccine Revenue by Type (2016-2026)
5.3 Global Varicella Live Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Varicella Live Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Varicella Live Vaccine Revenue by Application (2016-2026)
6.3 Global Varicella Live Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Varicella Live Vaccine Sales by Type (2016-2026)
7.2 North America Varicella Live Vaccine Sales by Application (2016-2026)
7.3 North America Varicella Live Vaccine Market Size by Country
7.3.1 North America Varicella Live Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Varicella Live Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Varicella Live Vaccine Sales by Type (2016-2026)
8.2 Europe Varicella Live Vaccine Sales by Application (2016-2026)
8.3 Europe Varicella Live Vaccine Market Size by Country
8.3.1 Europe Varicella Live Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Varicella Live Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Varicella Live Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Varicella Live Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Varicella Live Vaccine Market Size by Region
9.3.1 Asia-Pacific Varicella Live Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Varicella Live Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Varicella Live Vaccine Sales by Type (2016-2026)
10.2 South America Varicella Live Vaccine Sales by Application (2016-2026)
10.3 South America Varicella Live Vaccine Market Size by Country
10.3.1 South America Varicella Live Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Varicella Live Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Varicella Live Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Varicella Live Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Varicella Live Vaccine Market Size by Country
11.3.1 Middle East & Africa Varicella Live Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Varicella Live Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Varicella Live Vaccine Typical Distributors
12.3 Varicella Live Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Varicella Live Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Varicella Live Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Pharma Inc. Major Business
Table 5. Astellas Pharma Inc. Varicella Live Vaccine Product and Services
Table 6. Astellas Pharma Inc. Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 8. CSL Limited Major Business
Table 9. CSL Limited Varicella Live Vaccine Product and Services
Table 10. CSL Limited Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Emergent BioSolutions, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Emergent BioSolutions, Inc. Major Business
Table 13. Emergent BioSolutions, Inc. Varicella Live Vaccine Product and Services
Table 14. Emergent BioSolutions, Inc. Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline plc Major Business
Table 17. GlaxoSmithKline plc Varicella Live Vaccine Product and Services
Table 18. GlaxoSmithKline plc Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Varicella Live Vaccine Product and Services
Table 22. Johnson & Johnson Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 24. MedImmune, LLC Major Business
Table 25. MedImmune, LLC Varicella Live Vaccine Product and Services
Table 26. MedImmune, LLC Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co., Inc. Major Business
Table 29. Merck & Co., Inc. Varicella Live Vaccine Product and Services
Table 30. Merck & Co., Inc. Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer, Inc. Major Business
Table 33. Pfizer, Inc. Varicella Live Vaccine Product and Services
Table 34. Pfizer, Inc. Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Pasteur Major Business
Table 37. Sanofi Pasteur Varicella Live Vaccine Product and Services
Table 38. Sanofi Pasteur Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Serum Institute of India Pvt. Ltd. Major Business
Table 41. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Product and Services
Table 42. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 44. Bavarian Nordic Major Business
Table 45. Bavarian Nordic Varicella Live Vaccine Product and Services
Table 46. Bavarian Nordic Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Mitsubishi Tanabe Pharma Corporation Basic Information, Manufacturing Base and Competitors
Table 48. Mitsubishi Tanabe Pharma Corporation Major Business
Table 49. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Product and Services
Table 50. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 52. Daiichi Sankyo Major Business
Table 53. Daiichi Sankyo Varicella Live Vaccine Product and Services
Table 54. Daiichi Sankyo Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Biological E Basic Information, Manufacturing Base and Competitors
Table 56. Biological E Major Business
Table 57. Biological E Varicella Live Vaccine Product and Services
Table 58. Biological E Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 60. Panacea Biotec Major Business
Table 61. Panacea Biotec Varicella Live Vaccine Product and Services
Table 62. Panacea Biotec Varicella Live Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Varicella Live Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 64. Global Varicella Live Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Varicella Live Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Varicella Live Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Varicella Live Vaccine Production Site of Key Manufacturer
Table 68. Global Varicella Live Vaccine Sales by Region (2016-2021e) & (K Units)
Table 69. Global Varicella Live Vaccine Sales by Region (2021-2026) & (K Units)
Table 70. Global Varicella Live Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Varicella Live Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Varicella Live Vaccine Sales by Type (2016-2021e) & (K Units)
Table 73. Global Varicella Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 74. Global Varicella Live Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Varicella Live Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Varicella Live Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 77. Global Varicella Live Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 78. Global Varicella Live Vaccine Sales by Application (2016-2021e) & (K Units)
Table 79. Global Varicella Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 80. Global Varicella Live Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Varicella Live Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Varicella Live Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 83. Global Varicella Live Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 84. North America Varicella Live Vaccine Sales by Country (2016-2021e) & (K Units)
Table 85. North America Varicella Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 86. North America Varicella Live Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Varicella Live Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Varicella Live Vaccine Sales by Type (2016-2021e) & (K Units)
Table 89. North America Varicella Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 90. North America Varicella Live Vaccine Sales by Application (2016-2021e) & (K Units)
Table 91. North America Varicella Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 92. Europe Varicella Live Vaccine Sales by Country (2016-2021e) & (K Units)
Table 93. Europe Varicella Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 94. Europe Varicella Live Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Varicella Live Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Varicella Live Vaccine Sales by Type (2016-2021e) & (K Units)
Table 97. Europe Varicella Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 98. Europe Varicella Live Vaccine Sales by Application (2016-2021e) & (K Units)
Table 99. Europe Varicella Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Varicella Live Vaccine Sales by Region (2016-2021e) & (K Units)
Table 101. Asia-Pacific Varicella Live Vaccine Sales by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Varicella Live Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Varicella Live Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Varicella Live Vaccine Sales by Type (2016-2021e) & (K Units)
Table 105. Asia-Pacific Varicella Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 106. Asia-Pacific Varicella Live Vaccine Sales by Application (2016-2021e) & (K Units)
Table 107. Asia-Pacific Varicella Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 108. South America Varicella Live Vaccine Sales by Country (2016-2021e) & (K Units)
Table 109. South America Varicella Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 110. South America Varicella Live Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Varicella Live Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Varicella Live Vaccine Sales by Type (2016-2021e) & (K Units)
Table 113. South America Varicella Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 114. South America Varicella Live Vaccine Sales by Application (2016-2021e) & (K Units)
Table 115. South America Varicella Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Varicella Live Vaccine Sales by Country (2016-2021e) & (K Units)
Table 117. Middle East & Africa Varicella Live Vaccine Sales by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Varicella Live Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Varicella Live Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Varicella Live Vaccine Sales by Type (2016-2021e) & (K Units)
Table 121. Middle East & Africa Varicella Live Vaccine Sales by Type (2021-2026) & (K Units)
Table 122. Middle East & Africa Varicella Live Vaccine Sales by Application (2016-2021e) & (K Units)
Table 123. Middle East & Africa Varicella Live Vaccine Sales by Application (2021-2026) & (K Units)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Varicella Live Vaccine Typical Distributors
Table 127. Varicella Live Vaccine Typical Customers
List of Figures
Figure 1. Varicella Live Vaccine Picture
Figure 2. Global Varicella Live Vaccine Sales Market Share by Type in 2020
Figure 3. Monovalent Vaccines
Figure 4. Multivalent Vaccines
Figure 5. Global Varicella Live Vaccine Sales Market Share by Application in 2020
Figure 6. Chicken Pox Immunization
Figure 7. Herpes Zoster Immunization
Figure 8. Measles Immunization
Figure 9. Others
Figure 10. Global Varicella Live Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Varicella Live Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Varicella Live Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Varicella Live Vaccine Sales (2016-2026) & (K Units)
Figure 32. Global Varicella Live Vaccine Production Capacity (2016-2026) & (K Units)
Figure 33. Global Varicella Live Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Varicella Live Vaccine Market Drivers
Figure 35. Varicella Live Vaccine Market Restraints
Figure 36. Varicella Live Vaccine Market Trends
Figure 37. Global Varicella Live Vaccine Sales Market Share by Manufacturer in 2020
Figure 38. Global Varicella Live Vaccine Revenue Market Share by Manufacturer in 2020
Figure 39. Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Varicella Live Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Varicella Live Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Varicella Live Vaccine Sales Market Share by Region (2016-2026)
Figure 43. Global Varicella Live Vaccine Revenue Market Share by Region (2016-2026)
Figure 44. North America Varicella Live Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Europe Varicella Live Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Varicella Live Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. South America Varicella Live Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Varicella Live Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Global Varicella Live Vaccine Sales Market Share by Type (2016-2026)
Figure 50. Global Varicella Live Vaccine Revenue Market Share by Type (2016-2026)
Figure 51. Global Varicella Live Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Varicella Live Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Global Varicella Live Vaccine Revenue Market Share by Application (2016-2026)
Figure 54. Global Varicella Live Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Varicella Live Vaccine Sales Market Share by Country (2016-2026)
Figure 56. North America Varicella Live Vaccine Revenue Market Share by Country (2016-2026)
Figure 57. North America Varicella Live Vaccine Sales Market Share by Type (2016-2026)
Figure 58. North America Varicella Live Vaccine Sales Market Share by Application (2016-2026)
Figure 59. Europe Varicella Live Vaccine Sales Market Share by Country (2016-2026)
Figure 60. Europe Varicella Live Vaccine Revenue Market Share by Country (2016-2026)
Figure 61. Europe Varicella Live Vaccine Sales Market Share by Type (2016-2026)
Figure 62. Europe Varicella Live Vaccine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Varicella Live Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Varicella Live Vaccine Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Varicella Live Vaccine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Varicella Live Vaccine Sales Market Share by Application (2016-2026)
Figure 67. South America Varicella Live Vaccine Sales Market Share by Country (2016-2026)
Figure 68. South America Varicella Live Vaccine Revenue Market Share by Country (2016-2026)
Figure 69. South America Varicella Live Vaccine Sales Market Share by Type (2016-2026)
Figure 70. South America Varicella Live Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Varicella Live Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Varicella Live Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Varicella Live Vaccine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Varicella Live Vaccine Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の水痘（水疱瘡）ワクチン市場 2021：企業別、地域別、種類・用途別 The Chickenpox (Varicella) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の生ワクチン市場 2021：企業別、地域別、種類・用途別 The Live Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 日本脳炎ワクチンの世界市場2018-2025 Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.…
- 世界のライブサウンドアンプ市場 2021：企業別、地域別、種類・用途別 The Live Sound Amplifiers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 豚ワクチンの世界市場2018-2025 In 2018, the global Pig Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Pig Vaccine. This study researches the m…